Literature DB >> 27060259

Oxidative phosphorylation and mitochondrial function differ between human prostate tissue and cultured cells.

Bernd Schöpf1, Georg Schäfer2,3, Anja Weber2, Heribert Talasz4, Iris E Eder2, Helmut Klocker2, Erich Gnaiger5.   

Abstract

Altered mitochondrial metabolism plays a pivotal role in the development and progression of various diseases, including cancer. Cell lines are frequently used as models to study mitochondrial (dys)function, but little is known about their mitochondrial respiration and metabolic properties in comparison to the primary tissue of origin. We have developed a method for assessment of oxidative phosphorylation in prostate tissue samples of only 2 mg wet weight using high-resolution respirometry. Reliable protocols were established to investigate the respiratory activity of different segments of the mitochondrial electron transfer system (ETS) in mechanically permeabilized tissue biopsies. Additionally, the widely used immortalized prostate epithelial and fibroblast cell lines, RWPE1 and NAF, representing the major cell types in prostate tissue, were analyzed and compared to the tissue of origin. Our results show that mechanical treatment without chemical permeabilization agents or sample processing constitutes a reliable preparation method for OXPHOS analysis in small amounts of prostatic tissue typically obtained by prostate biopsy. The cell lines represented the bioenergetic properties of fresh tissue to a limited extent only. Particularly, tissue showed a higher oxidative capacity with succinate and glutamate, whereas pyruvate was a substrate supporting significantly higher respiratory activities in cell lines. Several fold higher zinc levels measured in tissue compared to cells confirmed the role of aconitase for prostate-specific metabolism in agreement with observed respiratory properties. In conclusion, combining the flexibility of cell culture models and tissue samples for respirometric analysis are powerful tools for investigation of mitochondrial function and tissue-specific metabolism.
© 2016 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.

Entities:  

Keywords:  electron transfer system; high-resolution respirometry; mitochondria; oxidative phosphorylation; prostate metabolism

Mesh:

Substances:

Year:  2016        PMID: 27060259     DOI: 10.1111/febs.13733

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  15 in total

1.  Multiple metabolic pathways fuel the truncated tricarboxylic acid cycle of the prostate to sustain constant citrate production and secretion.

Authors:  Lilianne Frégeau-Proulx; Aurélie Lacouture; Line Berthiaume; Cindy Weidmann; Mario Harvey; Kevin Gonthier; Jean-François Pelletier; Bertrand Neveu; Cynthia Jobin; Dominic Bastien; Alain Bergeron; Yves Fradet; Louis Lacombe; Isabelle Laverdière; Chantal Atallah; Frédéric Pouliot; Étienne Audet-Walsh
Journal:  Mol Metab       Date:  2022-05-20       Impact factor: 8.568

2.  Effects of caffeine on brain antioxidant status and mitochondrial respiration in acetaminophen-intoxicated mice.

Authors:  Débora F Gonçalves; Cintia C Tassi; Guilherme P Amaral; Silvio T Stefanello; Cristiane L Dalla Corte; Félix A Soares; Thais Posser; Jeferson L Franco; Nélson R Carvalho
Journal:  Toxicol Res (Camb)       Date:  2020-10-21       Impact factor: 3.524

3.  The effect of respiration buffer composition on mitochondrial metabolism and function.

Authors:  Lucas C Wollenman; Matthew R Vander Ploeg; Mackinzie L Miller; Yizhu Zhang; Jason N Bazil
Journal:  PLoS One       Date:  2017-11-01       Impact factor: 3.240

4.  Respiratory analysis of coupled mitochondria in cryopreserved liver biopsies.

Authors:  Mercedes García-Roche; Alberto Casal; Mariana Carriquiry; Rafael Radi; Celia Quijano; Adriana Cassina
Journal:  Redox Biol       Date:  2018-03-22       Impact factor: 11.799

Review 5.  Mitochondrial oncobioenergetics of prostate tumorigenesis.

Authors:  Praveen Kumar Vayalil
Journal:  Oncol Lett       Date:  2019-08-27       Impact factor: 2.967

6.  Redox mechanism of levobupivacaine cytostatic effect on human prostate cancer cells.

Authors:  Caroline Jose; Etienne Hebert-Chatelain; Nivea Dias Amoedo; Emmanuel Roche; Emilie Obre; Didier Lacombe; Hamid Reza Rezvani; Philippe Pourquier; Karine Nouette-Gaulain; Rodrigue Rossignol
Journal:  Redox Biol       Date:  2018-05-31       Impact factor: 11.799

7.  Assessment of mitochondrial function in metabolic dysfunction-associated fatty liver disease using obese mouse models.

Authors:  Qiong-Ya Zhao; Ling-Hong Ge; Kun Zhang; Hai-Feng Chen; Xin-Xin Zhan; Yue Yang; Qing-Lin Dang; Yi Zheng; Huai-Bin Zhou; Jian-Xin Lyu; He-Zhi Fang
Journal:  Zool Res       Date:  2020-09-18

8.  Succinate Accumulation Is Associated with a Shift of Mitochondrial Respiratory Control and HIF-1α Upregulation in PTEN Negative Prostate Cancer Cells.

Authors:  Anja Weber; Helmut Klocker; Herbert Oberacher; Erich Gnaiger; Hannes Neuwirt; Natalie Sampson; Iris E Eder
Journal:  Int J Mol Sci       Date:  2018-07-21       Impact factor: 5.923

9.  Metformin intervention prevents cardiac dysfunction in a murine model of adult congenital heart disease.

Authors:  Julia C Wilmanns; Raghav Pandey; Olivia Hon; Anjana Chandran; Jan M Schilling; Elvira Forte; Qizhu Wu; Gael Cagnone; Preeti Bais; Vivek Philip; David Coleman; Heidi Kocalis; Stuart K Archer; James T Pearson; Mirana Ramialison; Joerg Heineke; Hemal H Patel; Nadia A Rosenthal; Milena B Furtado; Mauro W Costa
Journal:  Mol Metab       Date:  2018-11-15       Impact factor: 7.422

10.  Caenorhabditis elegans as a model for studies on quinolinic acid-induced NMDAR-dependent glutamatergic disorders.

Authors:  Tássia Limana da Silveira; Marina Lopes Machado; Fabiane Bicca Obetine Baptista; Débora Farina Gonçalves; Diane Duarte Hartmann; Larissa Marafiga Cordeiro; Aline Franzen da Silva; Cristiane Lenz Dalla Corte; Michael Aschner; Felix Alexandre Antunes Soares
Journal:  Brain Res Bull       Date:  2021-07-13       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.